An increasing awareness of the disease, new diagnostic tools and novel therapeutic
opportunities have dramatically changed the management of patients with amyloid …

Background and Objectives Atrial fibrillation is common in patients with cardiac amyloidosis.
However, the optimal anticoagulation strategy to prevent thromboembolic events in patients …

Background: Intracardiac thrombosis is common in transthyretin amyloid cardiomyopathy
(ATTR-CM), and patients are at risk for thromboembolic events. However, silent cerebral …

Immunoglobulin light chain (AL) amyloidosis is a disorder of clonal plasma cells
characterized by deposition of amyloid fibrils in a variety of tissues, leading to end-organ …

Cardiac amyloidosis is the most frequent infiltrative disease caused by the deposition of
misfolded proteins in the cardiac tissue, leading to heart failure, brady-and tachyarrhythmia …

Introduction Both atrial fibrillation (AF) and amyloidosis increase stroke risk. We evaluated
the best anticoagulation strategy in AF patients with coexistent amyloidosis. Methods …